POL7085 or anti‐CCL28 treatment inhibits development of post‐paramyxoviral airway disease

INTRODUCTION: Asthma is major health burden throughout the world, and there are no therapies that have been shown to be able to prevent the development of disease. A severe respiratory paramyxoviral infection early in life has been demonstrated to greatly increase the risk of developing asthma. We h...

Descripción completa

Detalles Bibliográficos
Autores principales: Buelow, Becky J., Rohlfing, Michelle, Jung, Françoise, Douglas, Garry J., Grayson, Mitchell H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418136/
https://www.ncbi.nlm.nih.gov/pubmed/28474501
http://dx.doi.org/10.1002/iid3.147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418136/
https://www.ncbi.nlm.nih.gov/pubmed/28474501
http://dx.doi.org/10.1002/iid3.147

Ejemplares similares